Linking stages of non-rapid-eye-movement sleep to the spectral EEG markers of the drives for sleep and wake

Author(s):  
Vladimir Dorokhov ◽  
Anton Taranov ◽  
Dmitry Sakharov ◽  
Svetlana Gruzdeva ◽  
Olga Tkachenko ◽  
...  

The conventional staging classification reduces all patterns of sleep polysomnogram signals to a small number of yes-or-no variables labeled wake or a stage of sleep (e.g., W, N1, N2, N3, and R for wake, the 1st, 2nd and 3rd stages of non-rapid-eye-movement sleep, and rapid-eye-movement sleep, respectively). However, the neurobiological underpinnings of such stages remained to be elucidated. We tried to evaluate their link to scores on the 1st and 2nd principal components of the EEG spectrum (1PCS and 2PCS), the markers of two major groups of promoters/inhibitors of sleep/wakefulness delineated as the drives for sleep and wake, respectively. On two occasions, polysomnographic records were obtained from 69 university students during 50-min afternoon naps, and 30-s stage epochs were assigned to 1PCS and 2PCS. Results suggested two-dimensionality of the structure of individual differences in amounts of stages. Amount of N1 loaded exclusively on one of two dimensions associated with 1PCS, amounts of W and N2 loaded exclusively on another dimension associated with 2PCS, and amount of N3 equally loaded on both dimensions. Scores demonstrated stability within each stage, but a drastic change in just one of two scores occurred during transitions from one stage to another on the way from wakefulness to deeper sleep (e.g., 2PCS changed from >0 to <0 during transition W→N1, 1PCS changed from <0 to >0 during transition N1→N2). Therefore, the transitions between stages observed during short naps might be linked to rapid changes in the reciprocal interactions between the promoters/inhibitors of sleep/wakefulness.

2013 ◽  
Vol 27 (11) ◽  
pp. 1070-1075 ◽  
Author(s):  
Vladimira Jakubcakova ◽  
M Letizia Curzi ◽  
Cornelia Flachskamm ◽  
Boris Hambsch ◽  
Rainer Landgraf ◽  
...  

Methylglyoxal (MG), an essential by-product of glycolysis, is a highly reactive endogenous α-oxoaldehyde. Although high levels of MG are cytotoxic, physiological doses of MG were shown to reduce anxiety-related behavior through selective activation of γ-aminobutyric acid type A (GABAA) receptors. Because the latter play a major role in sleep induction, this study examined the potential of MG to regulate sleep. Specifically, we assessed how MG influences sleep-wake behavior in CD1 mice that received intracerebroventricular injections of either vehicle or 0.7 µmol MG at onset of darkness. We used electroencephalogram (EEG) and electromyogram (EMG) recordings to monitor changes in vigilance states, sleep architecture and the EEG spectrum, for 24 h after receipt of injections. Administration of MG rapidly induced non-rapid eye movement sleep (NREMS) and, concomitantly, decreased wakefulness and suppressed EEG delta power during NREMS. In addition, MG robustly enhanced the amount and number of episodes of an unclassified state of vigilance in which EMG, as well as EEG delta and theta power, were very low. MG did not affect overall rapid eye movement sleep (REMS) in a given 24-h period, but significantly reduced the power of theta activity during REMS. Our results provide the first evidence that MG can exert sleep-promoting properties by triggering low-amplitude NREMS.


2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Minji Lee ◽  
Benjamin Baird ◽  
Olivia Gosseries ◽  
Jaakko O. Nieminen ◽  
Melanie Boly ◽  
...  

2010 ◽  
Vol 110 (5) ◽  
pp. 1283-1289 ◽  
Author(s):  
George A. Mashour ◽  
William J. Lipinski ◽  
Lisa B. Matlen ◽  
Amanda J. Walker ◽  
Ashley M. Turner ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document